Current status of drugs used to treat hyperlipoproteinemias.
D010131:Aminosalicylic Acid / Q000627:therapeutic use; D002792:Cholestyramine Resin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003084:Colestipol / Q000627:therapeutic use; D004790:Enzyme Induction / Q000187:drug effects; D006801:Humans; D006951:Hyperlipoproteinemias / Q000178:diet therapy / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008075:Lipoproteins, HDL / Q000502:physiology; D008077:Lipoproteins, LDL / Q000502:physiology; D009355:Neomycin / Q000627:therapeutic use; D009525:Niacin; D009539:Nicotinic Acids / Q000627:therapeutic use; D011341:Probucol / Q000627:therapeutic use; D012855:Sitosterols / Q000627:therapeutic use
D000960:Hypolipidemic Agents; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D009539:Nicotinic Acids; D012855:Sitosterols; D002792:Cholestyramine Resin; D009525:Niacin; D010131:Aminosalicylic Acid; D009355:Neomycin; D003084:Colestipol; D011341:Probucol